Lactiplantibacillus plantarum LP-Onlly 500 Billion CFU/g Vegan/Allergen Free/Gluten Free/Dairy Free

Product Description

 
Lactiplantibacillus plantarum LP-Onlly 500 Billion CFU/g Vegan/Allergen Free/Gluten Free/Dairy Free
 
Brief Introduction
Lactiplantibacillus plantarum LP-Onlly screened and originates from healthy infant, is manufactured in China and deposited under CGMCC No.1258 at the China General Microbiological Culture Collection Center and CNCM No. I-4459 at the Collection Nationale de Cultures de Microorganismes in France. The strain Lactiplantibacillus plantarum has been subjected to API 50CHL sugar fermentation pattern analysis and a 16 S rDNA sequence analysis.And it has resistance to acid and bile.
 
Technical Data Sheet

Appearance

Off white to light yellow powder.

Classification of Product

Food and Dietary supplements ingredients

Shelflife & Storage

 24 months under the condition of ≤ -18℃ 

Gluten free statement

Lactiplantibacillus plantarum LP-Onlly does not consist of, nor contains, nor is produced from cereals containing gluten and is free of gluten.

Vegan, Vegetarian, Dairy free, BSE/TSE statement

Lactiplantibacillus plantarum LP-Onlly is manufactured without raw materials of animal origin, and is consequently free from BSE/TSE risk and Dairy free. It is suitable for vegan and vegetarian.

IRRADIATION, RESIDUAL SOLVENT, PESTICIDE, PAH, MYCOTOXIN,SEWAGE SLUDGE statement

Lactiplantibacillus plantarum LP-Onlly manufactured by the process of fermentation and freeze-drying, and is free from risk of irradiation, residual solvent, pesticide, PAH, mycotoxin sewage sludge.

HALAL,KOSHER statement

Lactiplantibacillus plantarum LP-Onlly is HALAL & KOSHER certified.

 
In vitro evaluation

1. Good acid tolerance ability
2. Satisfying tolerance to bile salts in human intestine
3. Anti-microbial ability
4. Adhesive ability

Animal study

1. High capacity to colonize in gastro-intestinal tract
2. The ability to regulate the intestinal microflora of mice with dysbacteriosis.
3. Enhance intestinal mucosal barrier
4. Improve the intestinal immunity

 
Clinical research

1. Regulate the intestinal microflora and promote gut health
2. Ease the symptoms of chronic gastritis
3. Enhance the intestinal barrier properties
4. Modify small intestine dysbacteriosis syndrome
5. Modify Irritable Bowel Syndrome
6. Improve the intestines and stomach function
7. Improve the immunity, lowering blood lipid and liver nutrition support

Probiotics Blend for Allergy Care

Products customized are acceptable.

Welcome to inquire and negotiate cooperation.

Reference:

[1]周朝晖,范小兵,傅昌年,等.昂立植物乳杆菌发酵及其稳定性能的研究[J].中国微生态学杂志,2004,(06):39-41.

[2]范小兵,杭晓敏,周朝晖,等.昂立植物乳杆菌耐酸,耐胆盐性能及相关表型,基因型分析[J].中国微生态学杂志,2004,(06):28-30.

[3]范小兵,周丛,杭晓敏,等.昂立植物乳杆菌粘附肠上皮细胞的研究[J].中国微生态学杂志,2004,(06):36-38.

[4]范小兵,周丛,杭晓敏,等.昂立植物乳杆菌及其抑菌物质的特性研究[J].中国微生态学杂志,2004,(06):33-35+38.

[5]李祎,范小兵,沙大年,等.昂立一号清除活性氧功能及其对化疗药物抗肿瘤协同作用的研究[J].中国微生态学杂志,2001,(01):29+33.

[6]范小兵,杭晓敏,张和春,等.昂立植物乳杆菌对腹腔感染大鼠肠道微生态的影响[J].中国微生态学杂志,2004,(06):31-32.

[7]张和春,杨国,王劲松,等.婴儿肠道细菌及乳杆菌种群多样性研究[J].中国微生态学杂志,2005,(04):276-277.

[8]张和春,蒋燕群,杭晓敏,等.昂立一号优菌多颗粒人群试食研究[J].中国微生态学杂志,2005,(05):23-24.

[9]余伯成,李红,范小兵,等.昂立品山抑瘤口服液抗小鼠肿瘤实验研究[J].上海医药,2002,(07):312-314.

[10]李祎 ,沙大年,胡卫乐,等.昂立品山抑瘤口服液抗辐射作用的实验观察[J].中国微生态学杂志,1999,(02):12.

[11]秦环龙,苏振东,范小兵,等.益生菌对急性胰腺炎大鼠肠道微生态及紧密连接的影响[J].中国临床营养杂志,2006,(02):82-86.

[12]王坚镪,丁在咸,张旻,等.益生菌对炎症性肠病小鼠肠道菌群紊乱及细菌移位的影响[J].上海交通大学学报(医学版),2010,30(02):186-190.

[13]储昭新.植物乳杆菌对IL-10基因敲除结肠炎小鼠黏附分子的影响[D].苏州大学,2010.

[14]杨建军,耿翔,高志光,等.益生菌及肠内外营养对重症急性胰腺炎大鼠肠道黏附分子及免疫屏障的影响[J].世界华人消化杂志, 2006, 14(010):953-957.

[15]张明,周玉坤,储昭新,等.植物乳酸杆菌对阻塞性黄疸大鼠肝紧密连接蛋白表达的影响[J].肠外与肠内营养,2009,16(05):298-302.

[16]严榕,傅昌年,周朝辉.植物乳杆菌对亚硝酸根离子的清除作用[J].食品工业,2003,(06):40-41..

[17]王一鸣,范小兵,杭晓敏,等.体外去除胆固醇菌株的筛选及其作用机理研究[J].微生物学通报,2006,(06):43-47.

[18]杨焱炯,张和春,周朝晖,等.具有降血压功能的益生菌的筛选[J].微生物学通报,2006,(05):28-30.

[19]沈通一,秦环龙,高志光,等.益生菌联合肠内营养对腹腔感染大鼠肠微生态及屏障功能的影响[J].中华胃肠外科杂志,2005,(05):443-446.

[20]张旻,张和春,杨国,等.植物乳杆菌体外降解结合胆盐与去除胆固醇能力研究[J].中国微生态学杂志,2008,(02):143-144.

[21]沈通一,张明,张鹏,等.植物乳酸杆菌CGMCC NO.1258表层黏附蛋白同致病性大肠埃希菌竞争黏附肠上皮细胞的研究[J].中国微生态学杂志,2009,21(05):403-406.

[22]张和春,潘玉辉,杨国,等.温度和渗透应激对植物乳杆菌稳定性的影响[J].中国微生态学杂志,2008,20(06):535-536+540.

[23]张和春,潘玉辉,杨国,等.弱酸(盐)对植物乳杆菌耐酸性的影响[J].中国微生态学杂志,2008,(01):15-16+19.

[24]蒋燕群,张和春,王坚镪,等.优菌多颗粒对人体肠道益生菌影响的初步研究[J].检验医学,2005,(06):81-83.

[25]张旻,张和春,杭晓敏.植物乳杆菌LP-ONLLY在发酵乳制品中的应用研究[C]//中国食品科学技术学会.乳酸菌与人体健康:第十届乳酸菌与健康国际研讨会摘要汇编.上海交大昂立股份有限公司;,2015:68-69.

[26]周朝晖,傅昌年,柳琴芳,等.昂立一号口服液人群试验[J].中国微生态学杂志,2002,(06):33-34.

[27]范小兵,沙大年,李慈娟,等.新昂立一号口服液与昂立一号口服液改善肠道菌群失调的研究[J].中国微生态学杂志,1998,(05):26-28.

[28]王劲松,张和春,周朝晖,等.昂立一号口服液长期保存的实验研究[J].中国微生态学杂志,2006,(05):359+362.

[29]贾素中,杭晓敏.复合益生菌发酵桑葚汁饮料的工艺优化[J].安徽农业科学,2018,46(12):172-174+188.

[30]杨俊,佟大年,秦环龙.益生菌联合谷氨酰胺对外科重症患者肠道屏障功能的影响[J].上海医学,2006,(08):527-529.

[31]Xia Y ,Hong㏎i Chen, Zhang M ,et al.Effect of Lactobacillus plantarum LP-Onlly on gut flora and colitis in interleukin-10 knockout mice.[J].Journal of Gastroenterology & Hepatology, 2011, 26.

[32]Zhou Y K , Qin H L , Zhang M ,et al.Effects of Lactobacillus plantarum on gut barrier function in experimental obstructive jaundice[J].World Journal of Gastroenterology, 2012, 18(30):15.DOI:10.3748/wjg.v18.i30.3977. 

[33]Chen H Q , Shen T Y , Zhou Y K ,et al.Lactobacillus plantarum consumption increases PepT1-mediated amino acid absorption by enhancing protein kinase C activity in spontaneously colitic mice.[J].Journal of Nutrition, 2010, 140(12):2201-6.

[34]Chu Z X , Chen H Q , Ma Y L ,et al.Lactobacillus plantarum prevents the upregulation of adhesion molecule expression in an experimental colitis model.[J].Digestive Diseases & Sciences, 2010, 55(9):2505-2513.

[35]Qin H L , Zheng J J , Tong D N ,et al.Effect of Lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis[J].European Journal of Clinical Nutrition, 2008, 62(7):923-930.